glp-1 agonists reduce inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury Anti-inflammatory role of glucagon-like peptide

Ill also give recommendations for those who are taking or are considering taking them for weight loss

Do GLP-1 agonists help with weight loss

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

Sarcopenia, or the age-related progressive loss of muscle mass and strength, has serious implications and is becoming more prevalent

Managing stress and optimizing sleep are often overlooked when it comes to weight loss and metabolic health

They were found to have significant HbA1c, and weight reduction compared to placebo in patients with diabetes and obesity respectively